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Background: Prenatal exposure to androgens has been linked to masculinization of several
traits.We aimed to determine whether putative female intra-uterine exposure to androgens
influences anthropometric, metabolic, and reproductive parameters using a twin design.
Methods: Two cohorts of Finnish twins born in 1975–1979 and 1983–1987 formed the
basis for the longitudinal FinnTwin16 (FT16) and FinnTwin12 (FT12) studies. Self-reported
anthropometric characteristics, disease status, and reproductive history were compared
between 679 same-sex (SS) and 789 opposite-sex (OS) female twins (mean age±SD:
34±1.1) from the wave 5 of data collection in FT16. Serum lipid and lipoprotein subclass
concentrations measured by nuclear magnetic resonance spectroscopy were compared
in 226 SS and 169 OS female twins (mean age±SD: 24±2.1) from the wave 4 of data
collection in FT12 and FT16.
Results: Anthropometric measures, the prevalence of hypertension and diabetes mellitus
type 2 did not differ significantly between females from SS and OS twin pairs at age 34.
Similarly, the prevalence of infertility, age at first pregnancy and number of induced and
spontaneous abortions did not differ significantly between these two groups of women.
The serum lipid and lipoprotein profile did not differ between females from SS and OS twins
at age 24.
Conclusion:We found no evidence that androgen overexposure of the female fetus affects
obesity, metabolic profile, or reproductive health in young adult females. However, these
results do not exclude the possibility that prenatal androgen exposure in females could be
adversely associated with these phenotypes later in life.
Keywords: prenatal androgen exposure, twin testosterone transfer hypothesis, opposite-sex twin pairs, anthropo-
metrics, reproductive history, lipoprotein profile
INTRODUCTION
Hyperandrogenism and insulin resistance are key features of poly-
cystic ovary syndrome (PCOS), and women with PCOS are conse-
quently at an increased risk of developing type 2 diabetes mellitus
and the metabolic syndrome (1). Increased ovarian androgen pro-
duction leads to premature adrenarche, menstrual irregularity,
acne, hirsutism, and infertility by means of elevated luteinizing
hormone to follicle stimulating hormone production and hyper-
insulinemia (2, 3). In addition to these important reproductive
outcomes, hyperandrogenism is associated with an adverse meta-
bolic profile, including obesity, particularly abdominal obesity
(4), hypertension (5), insulin resistance (6), type 2 diabetes (7),
dyslipidemia (8, 9), and subclinical atherosclerosis leading to
increased cardiovascular morbidity (10, 11). The onset and dura-
tion of exposure to excess androgens required to induce metabolic
and reproductive anomalies is unknown. However, it has been
hypothesized that intra-uterine exposure to androgens can accel-
erate hyperandrogenism-related phenotypes through epigenetic
mechanisms (12, 13). A natural experiment to test the intra-
uterine exposure hypothesis is the existence of same-sex (SS) and
opposite-sex (OS) twin pairs, with the premise that females in
OS twin pregnancies may be exposed to androgens from the male
www.frontiersin.org March 2014 | Volume 5 | Article 28 | 1
Korsoff et al. Prenatal androgens and PCOS-related phenotypes
fetus (14), while females from female–female pairs are not. In a
Swedish study of over 17,000 female twins, females from OS twin
pairs showed a more adverse anthropometric and metabolic profile
than females from SS twin pairs. However, the differences between
the zygosity groups were only observed in those females who were
over 60 years of age (15).
We examined anthropometric and metabolic signs of hyper-
androgenism and reproductive health in two large longitudinal
studies of twins, which include females from SS and OS DZ twin
pairs. The analysis is restricted to DZ pairs to avoid confound-
ing from the greater variability in placentation patterns among
monozygotic twin pairs. Variables related to anthropometric char-
acteristics, disease status, and reproductive history were examined
in the wave 5 study of the Finntwin16 (FT16) study, when the sub-
jects were aged 34 years on average, while information on lipids
was available from two clinical subsamples studied in their 20s.
We found no evidence for any phenotype for differences between
women from SS and OS twin pairs.
MATERIALS AND METHODS
THE TWIN COHORTS
The sample was derived from two population-based longitudi-
nal studies, FinnTwin16 and FinnTwin12 (FT12) (16, 17). Both
are longitudinal studies of behavioral development and health
habits of Finnish twins initially enrolled during adolescence, and
repeatedly assessed by self-report questionnaires. FT12 included
five consecutive birth cohorts of Finnish twins born in 1983–1987.
Questionnaires were mailed to twin individuals in the autumn of
the year in which their birth cohort reached age 11 (90% of the
responses were received by the end of that year), and subsequent
follow-up assessments were made at 14, 17.5, and ~22 years. A
subsample of the wave four participants was assessed in person in
Helsinki, at which time a fasting blood sample was taken. In FT16,
the baseline survey questionnaire was sent to all Finnish twins born
in 1975–1979 within 2 months after their 16th birthday (response
rate of 88%) and individuals were mailed four follow-up ques-
tionnaires at 17, 18.5, ~25, and 34 years. After the fourth wave,
some of the twins were invited to more detailed clinical assess-
ments in Helsinki, and a blood sample was taken in the morning
of the assessment. Serum lipid and lipoprotein measurements were
derived from these two sets of blood samples collected when the
twins were in their mid-20s. The fifth wave of data collection of the
FT16 cohort was done between October 2010 and November 2011
for Finnish speaking subjects and in the spring of 2012 for Swedish
speaking subjects. The invitation to take part in an internet survey
was sent to all twins in the cohort (born 1975–1979) living in Fin-
land irrespective of earlier participation. Of the 6132 twins that we
contacted, 4246 provided adequate data, a response rate of 69%.
There were 679 female twins of SS pairs and 789 female twins from
OS pairs. Mean age was 34.0 years, SD 1.13, range 31.9–37.3, with
no difference by zygosity status.
Subjects completed questionnaires on anthropometric char-
acteristics, medical status, and reproductive history. BMI (kilo-
grams per square meter) was calculated from self-reported height
(meters) and weight (kilograms). Waist circumference was self-
measured and self-reported at the level midway between the lowest
rib and the iliac crest according to the instructions supplied with
a picture. Medical history was assessed with the question: “Has a
doctor ever told you that you suffer or have suffered from hyper-
tension, diabetes mellitus type 1 or type 2?” Response options were
“yes” or “no” for each item. Reproductive history was assessed as
follows: are you currently pregnant (yes/no), do you have children
of which you are the biological parent (yes/no), have you ever
had a spontaneous abortion (yes/no) and the number of children
(open answer). The age at first pregnancy was computed from the
mother birth year and year of first birth. Infertility was measured
by one item: “have you ever tried to become pregnant for more
than 1 year without achieving a pregnancy?”
SAMPLE CHARACTERISTICS OF THE TWINS WITH LIPID
MEASUREMENTS
Serum lipid and lipoprotein subclass concentrations were mea-
sured by proton nuclear magnetic resonance (NMR) spectroscopy
(18, 19). The 14 lipoprotein subclass sizes determined by this
methodology are as follows: chylomicrons and extremely large
VLDL particles (with particle diameters from ~75 nm upwards),
five different VLDL subclasses, namely, very large VLDL (aver-
age particle diameter of 64.0 nm), large VLDL (53.6 nm), medium
VLDL (44.5 nm), small VLDL (36.8 nm), very small VLDL
(31.3 nm); IDL (28.6 nm), three LDL subclasses as large LDL
(25.5 nm), medium LDL (23.0 nm), and small LDL (18.7); and
four HDL subclasses as very large HDL (14.3 nm), large HDL
(12.1 nm), medium HDL (10.9 nm), and small HDL (8.7 nm).
We grouped extremely large, very large, and large VLDL to “large
VLDL,” small and very small VLDL to “small VLDL,” IDL and
large LDL to “large LDL” and very large and large HDL to “large
HDL.”Thus, three subclasses (large, medium, and small) of VLDL,
LDL, and HDL were analyzed. The mean particle size for VLDL,
LDL, and HDL particles was calculated by weighting the corre-
sponding subclass diameters with their particle concentrations.
Apolipoprotein B (apoB) and apolipoprotein A-1 (apoA-1) were
estimated from an extended version of the Friedewald formula
(20). NMR spectroscopy measurements were available for 436 DZ
female twins (249 SS and 187 OS twins). The exclusion criteria
were lipid-lowering medication (n= 1) and pregnancy (n= 40).
Thus, the final sample comprised 395 DZ female twins (226 SS
and 169 OS twins). Mean age was 23.9 years, SD 2.1, range 21–29,
with no difference by zygosity status. Data collection and analysis
were approved by the ethics committee of the Department of Pub-
lic Health of the University of Helsinki, ethics committee of the
Helsinki University Hospital District, and the Institutional Review
Board (IRB) of Indiana University. Written informed consent was
obtained from all participants.
STATISTICAL METHODS
For the wave 5 questionnaire data of FT16, we tested differences
between women from SS and OS pairs by an adjusted Wald test
for continuous variables and Chi2/design-based F for categorized
variables to take into account the clustering of twins in twin pairs.
Sample sizes varied somewhat due to non-response to selected
items.
For the wave 4 lipoprotein data of FT12 and FT16 subjects, dif-
ferences between SS and OS DZ female twins were tested by the
Wald tests for independent samples (t-tests adapted for clustered
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twin data). Because the distribution of most lipid measures was
highly skewed, variables were standardized by cohort and trans-
formed using rank transformation methods in R version 2.14.0.
The standard errors were corrected for clustering of twin pairs
by survey methods (21). Principal component analysis was used
to determine the number of principal components that explain
most of the variance of the studied lipids and lipoproteins. As the
strong correlations among these metabolites makes the traditional
Bonferroni correction for multiple testing too conservative, the
number of principal components provides a more permissive P-
value threshold. In this study, the first five principal components
explained more than 95% of the variance, allowing associations
to be significant at P < 0.01 after the Bonferroni correction. Sam-
ple sizes vary slightly in statistical analyses because of missing
data (n= 353–395). Statistical analyses were conducted using the
Stata statistical software package (release 12.0; Stata Corporation,
College Station, TX, USA).
RESULTS
Characteristics for females from SS and OS twin pairs are shown
in Table 1. The females were normal weight based on BMI. There
were no significant differences in height or adiposity measures
(BMI and waist circumference) between females from SS and OS
twin pairs. The prevalence of hypertension, type 1 diabetes mel-
litus and type 2 diabetes mellitus was low in both zygosity types
and did not differ significantly between SS and OS female twins.
The reproductive history was similar between the zygosity
groups of females. There were no differences in the age at the
first pregnancy, the number of biological children, and the num-
ber of spontaneous abortions between females from SS and OS
twin pairs. Females from SS pairs were more likely to be currently
pregnant (10.2 vs. 7.4%, P = 0.058). The prevalence of infertility
of more than 1 year duration did not differ significantly between
the two groups of women (Table 1).
Serum lipids and lipoproteins concentrations for females from
SS and OS twin pairs are shown in Table 2. Females from
SS twin pairs had higher concentrations of serum triglycerides
(mean± SD: 1.13± 0.51 vs. 1.01± 0.43, P = 0.038). However,
only a P-value below 0.01 was considered statistically significant
after Bonferroni correction. None of the other serum lipid and
lipoprotein subclass concentrations differed significantly between
females from SS and OS twin pairs (Table 2).
DISCUSSION
The hypothesis that prenatal hormone transfer from the male co-
twin may result in masculinization of females, and therefore pre-
dispose them to endocrine disorders can be tested by comparing
females from SS and OS twin pairs, i.e., females in utero with a male
as compared to a female co-twin. Therefore, if prenatal andro-
gen exposure influences phenotypes related to hyperandrogenism,
females from OS twin pairs are expected to have a higher BMI,
higher prevalence of type 2 diabetes and hypertension and a more
adverse lipid profile than females from SS pairs. However, in the
present study we did not find significant differences in anthropo-
metric measures, disease status, and reproductive history between
females from SS and OS twin pairs. We cannot exclude the possi-
bility of minor differences despite a fairly substantial sample size.
Table 1 | Obesity measures, disease status, and reproductive
characteristics for females from same-sex (SS) and opposite-sex (OS)
dizygotic twin pairs.
Variable SS females
(n=679)
OS females
(n=789)
P -value
Height (m), mean and SD 1.66±6.1 1.66±5.6 0.19
BMI (kg/m2), mean and SD 24.2±4.9 23.9±4.4 0.34
Waist circumference (cm) mean
and SD
81.9±12.3 81.4±11.7 0.48
Hypertension (%) 1.78 1.81 0.97
Type 1 diabetes (%) 0.89 0.65 0.60
Type 2 diabetes (%) 0.75 1.17 0.42
Current pregnancy (%) 10.2 7.4 0.06
Age at the first pregnancy, years 29.6 29.2 0.53
Prevalence of biological children (%) 62.2 66.1 0.12
Number of biological children (%)
1 Child 32.1 31.3
2 Children 44.5 46.4
3 Children 16.4 16.2
4 Children 4.5 3.8
5 Children 2.6 2.3 0.97
Spontaneous abortions (%)
Once 16.2 13.6
2 Or more 4.1 4.2 0.37
Infertility of >1 year duration (%) 15.8 15.5 0.93
P-value from the Wald test for continuous variables and Chi2/design-based F for
categorized variables. Mean values (±SD) or percentages.
Missing values for height (n=10), BMI (12), and waist (n=61).
Wave 5 of FinnTwin16.
The concept that individual variability in sex-related traits may
be influenced by variations in hormonal exposure during fetal
development is interesting and comes from animal studies with
placentation patterns, which are quite different from human twin
pregnancies (14). Female fetuses developing between two males
tend to show masculinized anatomical, physiological, and behav-
ioral traits as adults. Female fetuses developing without adjacent
males, on the other hand, tend to show more feminized traits as
adults. These traits include permanently altered hormone levels,
reproductive organs, aggressive behaviors, secondary sex ratios,
and susceptibility to endocrine disruption. This intra-uterine
effect is due to the transfer of testosterone from male fetuses to
adjacent fetuses (14).
It is questionable whether prenatal testosterone transfer occurs
in humans. Thus far direct evidence for the existence of prena-
tal testosterone transfer in females from OS twin pregnancies
is missing. Testosterone is a steroid hormone; therefore it has
the ability to diffuse through the amniotic fluid between fetuses
(22). In addition, hormones can transfer among fetuses through
the mother’s bloodstream (23). Evidence is mounting, however,
for in utero testosterone excess, together with gestational hyper-
glycemia, contributing to either early differentiation of PCOS or
phenotypic amplification of its genotypes. Abnormal endocrine,
ovarian, and hyperinsulinemic traits are detectable as early as
www.frontiersin.org March 2014 | Volume 5 | Article 28 | 3
Korsoff et al. Prenatal androgens and PCOS-related phenotypes
Table 2 | Serum lipid and lipoprotein profile for females from same-sex
(SS) and opposite-sex (OS) twin pairs.
SS females
(n=226)
OS females
(n=169)
P -value
LIPOPROTEIN PARTICLE CONCENTRATIONS
Large VLDL (and
chylomicrons) (nmol/l)
4.18±4.01 3.51±3.12 0.14
Medium VLDL (nmol/l) 13.79±8.63 12.28±6.70 0.17
Small VLDL (nmol/l) 54.08±17.59 50.07±16.79 0.05
Large LDL (nmol/l) 241.35±56.90 230.61±58.50 0.07
Medium LDL (nmol/l) 119.18±30.70 114.03±31.03 0.12
Small LDL (nmol/l) 136.64±33.97 130.33±33.99 0.10
Large HDL (µmol/l) 2.05±0.78 2.06±0.68 0.92
Medium HDL (µmol/l) 2.46±0.45 2.37±0.46 0.07
Small HDL (µmol/l) 4.87±0.54 4.76±0.56 0.06
LIPOPROTEIN PARTICLE SIZE
VLDL diameter (nm) 36.53±1.48 36.39±1.47 0.50
LDL diameter (nm) 23.60±0.18 23.60±0.16 0.86
HDL diameter (nm) 10.10±0.25 10.12±0.23 0.45
APOLIPOPROTEINS
ApoA-1 (g/l) 1.89±0.22 1.88±0.22 0.63
ApoB (g/l) 0.84±0.19 0.81±0.17 0.31
ApoB/ApoA-1 ratio 0.45±0.10 0.44±0.09 0.57
TRIGLYCERIDES
Total triglycerides (mmol/l) 1.13±0.51 1.01±0.43 0.04
Extremely large VLDL-TG
(mmol/l)
0.01±0.01 0.01±0.01 0.05
Total VLDL-TG (mmol/l) 0.70±0.44 0.62±0.35 0.13
CHOLESTEROL
Total cholesterol (mmol/l) 4.99±0.90 4.86±0.89 0.23
IDL-C (mmol/l) 0.70±0.16 0.68±0.16 0.38
LDL-C (mmol/l) 1.72±0.48 1.66±0.49 0.20
HDL-C (mmol/l) 2.01±0.42 1.99±0.37 0.67
HDL2-C (mmol/l) 1.49±0.45 1.47±0.39 0.84
HDL3-C (mmol/l) 0.53±0.06 0.52±0.05 0.63
HDL-C/LDL-C ratio 1.26±0.47 1.30±0.44 0.43
P-value from the Wald tests for independent samples. Mean values (±SD).
Statistical significance at P<0.01 after Bonferroni correction.
Wave 4 clinical subsample data from FinnTwin12 and FinnTwin16.
2 months of age in daughters of women with PCOS, with adipos-
ity enhancement of hyperinsulinemia during childhood poten-
tially contributing to hyperandrogenism and luteinizing hormone
excess by adolescence (12).
There is indirect evidence that human fetuses gestated with a
male co-twin may be masculinized in development, perhaps due
to the influence of prenatal androgens: the so-called twin testos-
terone transfer hypothesis. Results from studies in humans using
a number of traits that show distinct sexual dimorphism are con-
flicting. Generally, the evidence for traits such as perception and
cognition is more consistent than for behaviors (24). For exam-
ple, we have shown a decreased prevalence of left-handedness and
better mental rotation performance among females with male co-
twins as compared to females with female co-twins (25, 26), a
finding consistent with the intra-uterine exposure hypothesis. On
the other hand, for a variety of personality and fertility traits, we
have shown no differences between females from like and OS DZ
pairs (27). Some studies have reported that females from OS twin
pairs show an increased tooth size (28), adverse anthropomet-
ric, and metabolic parameters (15), increased alcohol use disorder
symptoms (29), increased risk for alcohol dependence (30), greater
sensation seeking (31), and enhanced aggressive behaviors (32) as
compared to female twins from SS twin pairs. However, the present
literature is far from consistent, and negative reports exist for sev-
eral traits, including, anthropometric measures (33), birth weight
(34), disordered eating (35, 36), and fertility (27).
The only twin study examining the prenatal exposure effects
of androgens on the prevalence of PCOS found no differences
between women from OS (480 women) and SS twin pairs (711
women) (37). PCOS was defined as less than nine natural men-
strual cycles a year combined with either hirsutism or acne, which
is not a fully satisfactory definition of PCOS. Our results were in
good agreement with the study of Kuijper et al. (37), although
we did not study PCOS per se, but compared parameters related
to the androgenic phenotype including BMI, waist circumference,
hypertension, type 2 diabetes mellitus, infertility, and the serum
lipid profile.
According to the prenatal testosterone exposure hypothesis, the
women with a twin brother in the present study would be expected
to be more prone to the hyperandrogenism-related phenotypes.
However, they tended to have a more favorable serum lipopro-
tein profile than women from SS pairs, albeit these differences
did not reach statistical significance after correction for multi-
ple comparisons. Testosterone administration has been shown to
decrease measured HDL, which is associated with atherosclerosis
(38). It is possible that the higher HDL concentrations associ-
ated with female gender contradicts the effect of intra-uterine
hyperandrogenism.
An early onset of menarche has been associated with body fat-
ness (39) and early menarche has been suggested to trigger the
development of the metabolic syndrome and incidence of PCOS
(40). We previously reported that the women from OS DZ twin
pairs had a significantly higher mean age at menarche (13.3 years)
compared to the women from DS pairs (13.1 years) (41). This is a
small difference and one that is unlikely to be of clinical relevance.
Non-classical congenital adrenal hyperplasia (NCAH) due to
21-hydroxylase deficiency is the most common inherited disor-
der of adrenal steroid biosynthesis. Patients with the classic form
of NCAH show androgen excess, with or without salt wasting.
The factors that associate with increased risk for adverse meta-
bolic consequences cluster in women with NCAH and include
obesity, hypertension, and insulin resistance. The androgen excess
may independently contribute to this increased risk due to athero-
genic lipid profiles (42). Comparison of metabolic parameters
in women with PCOS, women with NCAH, and healthy con-
trol women showed that metabolic parameters were comparable
among women with NCAH, lean women with PCOS, and healthy
control women whereas metabolic dysfunction was evident in the
obese women with PCOS (43).
There are some weaknesses in our study. We measured only phe-
notypes related to hyperandrogenism and not the plasma levels
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of androgens. As for PCOS, we did not have any questionnaire
items concerning oligomenorrea nor clinical signs for hyperan-
drogenism (e.g., hirsutism). The subjects of the present study were
young adults and mostly healthy, which may explain why we did
not observe differences in disease status between SS and OS female
twins. Moreover, we cannot extrapolate our findings to middle-
aged or older females. The strength of our study includes the
twin study design, population-based sampling, and high response
rates, as well as the comprehensive analysis of serum lipoprotein
subclasses.
In conclusion, anthropometric characteristics, disease status,
and reproductive history did not differ between females from SS
and OS twin pairs. Thus, we found no evidence for the hypothesis
that prenatal hormone transfer from the male co-twin may result
in masculinization of females in regard to these PCOS-related phe-
notypes. However, these results do not exclude the possibility that
prenatal androgen exposure in females could be associated with
these phenotypes later in life.
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